Tender France

Design, commissioning and qualification of a RABS injectable-filling line (project management)

Reference 512051-2026
DAPSA Published auto-extracted, not yet reviewed

At a glance

Instrument
Tender
Application route
direct bid

Classification CPV 42611000

Why it matters

A rare defence-sector pharmaceutical production build-out in France, signalling investment in sovereign injectable medicine capacity for the armed forces. Relevant to pharma engineering firms, GMP qualification consultancies and clean-room/RABS integrators with French entities and defence clearance capacity.

Do this:

Retrieve the full tender pack on the French/TED portal and prepare a GMP-qualified maîtrise d'œuvre bid (aseptic filling, RABS, IQ/OQ/PQ references) before the 1 October 2026 deadline.

Summary

DAPSA (France) is tendering project management/engineering services (maîtrise d'œuvre) for the design, commissioning and qualification of a filling zone for injectable pharmaceutical products under a Restricted Access Barrier System (RABS).

PRO

This item is older than 14 days. Full details are in Pro.

Pro members get the full archive, eligibility & budget breakdowns, award data, weekly analyst brief and CSV/API export.

See pricing

Dates in this notice

  1. Published
  2. Deadline

Check the notice for the submission stage and exact time.

Organisations in this notice

BuyerDAPSA
This noticeTender512051-2026

Source & methodology

Source: Tenders Electronic Daily © European Union, reused under EU open data policy. Notice 512051-2026.

AI-extracted summary (claude-opus-5). confidence 70%.